Key Findings
This is a quick summary of the main discovery for each research paper we have published, organized issue by issue. Each key finding is below the article title, with a link to the abstract.
Search key findings View Previous Lists
August 2019
Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada
Injecting cessation episodes appear to protect against hepatitis C virus acquisition, particularly when maintained for at least 3 months.
Comparing alcohol taxation throughout the European Union
There is limited evidence that EU countries enact alcohol taxation policies to minimize public health harms; instead, tax rates appear to reflect national alcohol production and consumption patterns.
Use of publication procedures to improve research integrity by addiction journals
While many addiction journals have adopted publication procedures to improve research integrity, these can be limited by their voluntary nature and monitoring difficulties.
Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings
Substance use disorders among patients with type 2 diabetes mellitus (T2DM) and hypertension appear to raise the risk for T2DM complications and all‐cause mortality.
Are long‐term vapers interested in vaping cessation support?
A 2017 European online survey found that one‐quarter to one‐half of long-term vapers who intended to stop wanted vaping cessation support.
Cross‐national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys
Globally only a very small proportion of people with substance use disorder receive treatment, even when they have other mental health problems as well.
Cost‐effectiveness of real‐world administration of tobacco pharmacotherapy in the United States Veterans Health Administration
Use by the US Veterans Health Administration in 2011/12 of drugs to help people stop smoking cost just under $5000 per quit generated.
Long‐term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out‐patients with opioid use disorder
Monthly subcutaneous buprenorphine depot treatment appears to have a similar safety profile to sublingual buprenorphine. It also appears to have high retention rates and low levels of illicit opioid use.
The impact of flavors, health risks, secondhand smoke and prices on young adults’ cigarette and e‐cigarette choices: a discrete choice experiment
In a simulated choice situation young e-cigarette users in the use appear to value flavours and the reduced health effects of these products.
Structural brain characteristics of anabolic–androgenic steroid dependence in men
Male dependent anabolic-androgenic steroid users appear to have a thinner cortex in pre‐frontal areas involved in inhibitory control and emotional regulation compared with non‐dependent users.
Criminal justice outcomes over 5 years after randomization to buprenorphine‐naloxone or methadone treatment for opioid use disorder
In a US sample of people treated for opioid use disorder, continued treatment with either buprenorphine or methadone was associated with a reduction in arrests relative to no treatment.
The association between residential relocation and re‐incarceration among drug‐dependent former prisoners
In Louisiana, USA, drug‐dependent former prisoners whose homes were relocated following Hurricane Katrina had reduced likelihood of re‐incarceration than those who remained in their original homes.
Life after opioid‐involved overdose: survivor narratives and their implications for ER/ED interventions
Giving emergency medical staff brief training about current theories of addiction and evidence‐based treatment may improve delivery of emergency department interventions with opioid‐involved overdose (OD) survivors.
Delay discounting and reward sensitivity in a 2 × 2 study of bipolar disorder and alcohol dependence
Previously found associations between bipolar disorder and delay discounting may be secondary to alcohol use disorder.
Decomposing social inequalities in alcohol consumption in Germany 1995–2015: an age–period–cohort analysis
In Germany, there are positive associations between socio‐economic status and alcohol consumption during the life‐course, over time and among birth cohorts. Three groups appear to be vulnerable to risky drinking.